I agree, the current share price bears no reality in context to the achievements by NWBO thus far, the near-completion of phase 3 being just one, the other positive results from other clinical trials, their progress with storage/manufacturing hubs in US, Germany and the UK, five year licence in Germany, approval in the UK etc etc etc. In fact, had it not been for the short selling [both legit and not??] for sure a more realistic value would no doubt be reflected in the current share price. The science is good, have faith and this I have no doubt will be rewarded both in terms of us being that much closer to a permanent cancer cure and a decent return for enduring and believing. GLTA